Targeting IL-23R in the HLA-B27 transgenic rat, an experimental model that closely resembles human SpA, was not effective once arthritis was established but did have some beneficial impact in preventing the onset of disease, indicating IL-23 independent production of IL-17 in the perpetuation of disease (38). The gene discussed is IL17A; the disease is arthritic joint disease.